================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): FEBRUARY 22, 2005
TECHLABS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
FLORIDA 000-26233 65-0843965
--------------- ------------ ----------------------
State or other (Commission (IRS Employer
jurisdiction of File Number) Identification Number)
incorporation)
8905 KINGSTON PIKE, SUITE 307, KNOXVILLE, TN 37923
--------------------------------------------------
(Address of executive offices and Zip Code)
Registrant's telephone number, including area code: (215) 243-8044
NOT APPLICABLE
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (SEE General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 133-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 7.01 REGULATION FD DISCLOSURE.
On February 22, 2005, the Company issued a press release regarding its
plans to begin marketing a new proprietary natural supplement line under its
subsidiary Siren Labs, Inc. A copy of this press release is hereby incorporated
by reference and furnished as part of this Current Report as Exhibit 99.1.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits
99.1 Press Release issued February 22, 2005 regarding its plans to begin
marketing a new proprietary natural supplement line under its subsidiary Siren
Labs, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Eline Entertainment Group, Inc.
Date: February 22, 2005 By: /s/ Jayme Dorrough
---------------------------
Jayme Dorrough, President